Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, 43210, USA.
Laboratory of Cell and Developmental Signaling, National Cancer Institute-Frederick, Frederick, MD, 21702, USA.
Nat Commun. 2022 Jun 7;13(1):3153. doi: 10.1038/s41467-022-30881-9.
A distinct profile of NRAS mutants is observed in each tumor type. It is unclear whether these profiles are determined by mutagenic events or functional differences between NRAS oncoproteins. Here, we establish functional hallmarks of NRAS mutants enriched in human melanoma. We generate eight conditional, knock-in mouse models and show that rare melanoma mutants (NRAS G12D, G13D, G13R, Q61H, and Q61P) are poor drivers of spontaneous melanoma formation, whereas common melanoma mutants (NRAS Q61R, Q61K, or Q61L) induce rapid tumor onset with high penetrance. Molecular dynamics simulations, combined with cell-based protein-protein interaction studies, reveal that melanomagenic NRAS mutants form intramolecular contacts that enhance BRAF binding affinity, BRAF-CRAF heterodimer formation, and MAPK > ERK signaling. Along with the allelic series of conditional mouse models we describe, these results establish a mechanistic basis for the enrichment of specific NRAS mutants in human melanoma.
在每种肿瘤类型中都观察到 NRAS 突变体的独特特征。目前尚不清楚这些特征是由诱变事件还是 NRAS 癌蛋白之间的功能差异决定的。在这里,我们确定了在人类黑色素瘤中富集的 NRAS 突变体的功能特征。我们生成了八个条件性、敲入的小鼠模型,并表明罕见的黑色素瘤突变体(NRAS G12D、G13D、G13R、Q61H 和 Q61P)是自发黑色素瘤形成的不良驱动因素,而常见的黑色素瘤突变体(NRAS Q61R、Q61K 或 Q61L)则以高穿透率诱导快速肿瘤发生。分子动力学模拟,结合基于细胞的蛋白质-蛋白质相互作用研究,揭示了致黑色素瘤 NRAS 突变体形成增强 BRAF 结合亲和力、BRAF-CRAF 异二聚体形成和 MAPK>ERK 信号的分子内接触。结合我们描述的等位基因系列条件性小鼠模型,这些结果为 NRAS 突变体在人类黑色素瘤中的富集建立了一种机制基础。
JCEM Case Rep. 2025-4-11
RSC Chem Biol. 2024-11-25
Nat Commun. 2024-11-21
Int J Mol Sci. 2024-10-30
Oncogene. 2024-11
Front Pharmacol. 2024-9-20
Future Med Chem. 2020-11
Nucleic Acids Res. 2020-1-8
J Vis Exp. 2019-6-26
Nat Methods. 2018-7-16